Ausdal Financial Partners’s Tiziana Life Sciences TLSA Stock Holding History

Ausdal Financial Partners’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-55,700	Closed	-$53.5K	–	593
2024 Q3	$53.5K	Hold	55,700	–	–	0.01%	507
2024 Q2	$51.2K	Hold	55,700	–	–	0.01%	488
2024 Q1	$25.3K	Hold	55,700	–	–	﹤0.01%	465
2023 Q4	$31.2K	Hold	55,700	–	–	﹤0.01%	452
2023 Q3	$36.8K	Sell	55,700 -1,200	-2%	-$826	0.01%	427
2023 Q2	$38.8K	Hold	56,900	–	–	0.01%	425
2023 Q1	$62.1K	Hold	56,900	–	–	0.01%	435
2022 Q4	$34.1K	Hold	56,900	–	–	﹤0.01%	440
2022 Q3	$44K	Hold	56,900	–	–	0.01%	435
2022 Q2	$42K	Hold	56,900	–	–	0.01%	439
2022 Q1	$60K	Hold	56,900	–	–	0.01%	474
2021 Q4	$55K	Buy	56,900 +10,000	+21%	+$13.3K	0.01%	477
2021 Q3	$68K	Buy	46,900 +7,000	+18%	+$12.9K	0.01%	466
2021 Q2	$94K	Hold	39,900	–	–	0.01%	450
2021 Q1	$111K	Buy	39,900 +13,700	+52%	+$45.5K	0.02%	431
2020 Q4	$53K	Buy	26,200 +11,000	+72%	+$34.8K	0.01%	413
2020 Q3	$51K	Buy	+15,200	New	+$59.2K	0.01%	350

Other funds holding TLSA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ausdal Financial Partners's TLSA Position: Q4 2024 in Review

Ausdal Financial Partners sold out of Tiziana Life Sciences (TLSA) in Q4 2024, closing a stake of 55,700 shares — an estimated $53.5K sold.

Ausdal Financial Partners first reported a position in TLSA in Q3 2020 and held it in 17 quarters. The position peaked at $111K in Q1 2021. 33 funds tracked by Wall St. Rank hold TLSA as of Q4 2024.

Ausdal Financial Partners reported no remaining Tiziana Life Sciences position as of Q4 2024 after selling out during the quarter.
Ausdal Financial Partners sold 55,700 Tiziana Life Sciences shares in Q4 2024, an estimated $53.5K.
Ausdal Financial Partners first reported a position in Tiziana Life Sciences in Q3 2020 and held it in 17 quarters.
Ausdal Financial Partners's Tiziana Life Sciences position peaked at $111K in Q1 2021.
33 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2024.

Based on Ausdal Financial Partners's 13F filing for Q4 2024, filed 12 Feb 2025.